Clinical Trial

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated November 15, 2021 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a phase II randomized controlled clinical trial to assess the toxicities and clinical efficacy of prostate specific membrane antigen (PSMA) positron emission tomography / computed tomography (PET/CT) and multi- parameter Magnetic Resonance Imaging (MRI) guided simultaneous integrated boost for prostate cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-08-14.
Trial Details
NCT Number NCT05010343
Lead Sponsor Shanghai Proton and Heavy Ion Center
Conditions Localized Prostate Cancer
Enrollment 140 participants
Start Date 2020-10-15
Primary Completion 2025-07-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2021-11-15